MFDS — authorised 14 September 2018
- Marketing authorisation holder: TEVA PHARMS USA
- Status: likely_approved
🇰🇷 Ajovy in South Korea
MFDS authorised Ajovy on 14 September 2018
Marketing authorisation
Ajovy in other countries
Same drug, different regulators. Each page below lists the local marketing authorisation, HTA position, pricing, and adverse-event data.
Other Neuroscience approved in South Korea
Frequently asked questions
Is Ajovy approved in South Korea?
Yes. MFDS authorised it on 14 September 2018.
Who is the marketing authorisation holder for Ajovy in South Korea?
TEVA PHARMS USA holds the South Korean marketing authorisation.